Nope, but I suspect they have been working on the
Post# of 148172
CytoDyn plans to update its Breakthrough Therapy designation application and file for BTD for mTNBC
The data is world-class for mTNBC as far as survival improvements. Also, we should be able to design a trial with an extremely high success probability readily knowing which patients respond and which ones don't.